Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:9 Issue:10 Number:3 ISSN#:2563-5476
ACE Report #12369
Ace Report Cover Arthroplasty

Increased IV-TXA Dosage Reduces Blood Loss, Improves Pain and Clinical Outcomes in TKA Patients

How to Cite

OrthoEvidence. Increased IV-TXA Dosage Reduces Blood Loss, Improves Pain and Clinical Outcomes in TKA Patients. ACE Report. 2020;9(10):3. Available from: https://myorthoevidene.com/AceReport/Report/12369

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Additional benefits of multiple-dose tranexamic acid to anti-fibrinolysis and anti-inflammation in total knee arthroplasty: a randomized controlled trial.

Arch Orthop Trauma Surg. 2020 Aug;140(8):1087-1095

Contributing Authors: Y Lei J Xie Q Huang W Huang F Pei

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Two hundred and two patients with osteoarthrosis or rheumatoid arthritis undergoing a unilateral total knee arthroplasty were randomized to receive either one of the following interventions: 4 doses of Intravenous (IV) Tranexamic acid (TXA), 5 doses of IV-TXA, or 6 doses of IV-TXA or control (no TXA). The primary outcome of interest was hidden blood loss. Additional outcomes measured included the ...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.